ARGENX SE - ADR (ARGX) Stock Overview
NASDAQ:ARGX - US04016X1019 - ADR
ARGX Key Statistics, Chart & Performance
The current stock price of ARGX is 762.385 USD. In the past month the price increased by 20.05%. In the past year, price increased by 42.56%.
ARGX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.98 | 373.82B | ||
| AMGN | AMGEN INC | 12.77 | 149.94B | ||
| GILD | GILEAD SCIENCES INC | 14.81 | 142.21B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.12 | 100.42B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 61.38B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.19 | 58.96B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.49 | 37.36B | ||
| INSM | INSMED INC | N/A | 30.54B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.27B | ||
| NTRA | NATERA INC | N/A | 23.19B | ||
| BIIB | BIOGEN INC | 8.88 | 20.84B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.54 | 18.00B |
Related stock screener links
About ARGX
Company Profile
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. The company is headquartered in Amsterdam, Noord-Holland and currently employs 1,599 full-time employees. The company went IPO on 2014-07-10. The company is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The firm develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. The company includes, but is not limited to: Empasiprubart, a complement inhibitor targeting C2, blocking the function of both the classical and lectin pathways, while leaving the alternative pathway intact, ARGX-119 an antagonist to the MuSK receptor with potential in multiple neuromuscular indications.
Company Info
ARGENX SE - ADR
Laarderhoogtweg 25
Amsterdam NOORD-HOLLAND 4811 AH NL
CEO: Tim Van Hauwermeiren
Employees: 1599
Phone: 31763030
ARGENX SE - ADR / ARGX FAQ
What is the stock price of ARGENX SE - ADR today?
The current stock price of ARGX is 762.385 USD. The price decreased by -0.6% in the last trading session.
What is the ticker symbol for ARGENX SE - ADR stock?
The exchange symbol of ARGENX SE - ADR is ARGX and it is listed on the Nasdaq exchange.
On which exchange is ARGX stock listed?
ARGX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ARGENX SE - ADR stock?
25 analysts have analysed ARGX and the average price target is 831.9 USD. This implies a price increase of 9.12% is expected in the next year compared to the current price of 762.385. Check the ARGENX SE - ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ARGENX SE - ADR worth?
ARGENX SE - ADR (ARGX) has a market capitalization of 46.66B USD. This makes ARGX a Large Cap stock.
How many employees does ARGENX SE - ADR have?
ARGENX SE - ADR (ARGX) currently has 1599 employees.
What are the support and resistance levels for ARGENX SE - ADR (ARGX) stock?
ARGENX SE - ADR (ARGX) has a support level at 704.06. Check the full technical report for a detailed analysis of ARGX support and resistance levels.
Is ARGENX SE - ADR (ARGX) expected to grow?
The Revenue of ARGENX SE - ADR (ARGX) is expected to grow by 81.09% in the next year. Check the estimates tab for more information on the ARGX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ARGENX SE - ADR (ARGX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ARGX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ARGX, evaluating the profitability, health, valuation and growth aspects
- ARGENX SE - ADR (ARGX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ARGENX SE - ADR (ARGX) Sales and EPS estimates to see what analysts future expectations are.
- ARGENX SE - ADR (ARGX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ARGENX SE - ADR (ARGX) Insider and Institutional Ownership to learn about the owners and their transactions.
- ARGENX SE - ADR (ARGX) Stock Chart to make your own analysis
- ARGENX SE - ADR (ARGX) Latest news and press-releases to stay up to date.
Does ARGENX SE - ADR (ARGX) stock pay dividends?
ARGX does not pay a dividend.
When does ARGENX SE - ADR (ARGX) report earnings?
ARGENX SE - ADR (ARGX) will report earnings on 2025-10-30, before the market open.
What is the Price/Earnings (PE) ratio of ARGENX SE - ADR (ARGX)?
The PE ratio for ARGENX SE - ADR (ARGX) is 82.24. This is based on the reported non-GAAP earnings per share of 9.27 and the current share price of 762.385 USD. Check the full fundamental report for a full analysis of the valuation metrics for ARGX.
What is the Short Interest ratio of ARGENX SE - ADR (ARGX) stock?
The outstanding short interest for ARGENX SE - ADR (ARGX) is 2.95% of its float. Check the ownership tab for more information on the ARGX short interest.
ARGX Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ARGX. When comparing the yearly performance of all stocks, ARGX is one of the better performing stocks in the market, outperforming 88.66% of all stocks.
ARGX Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ARGX. ARGX has an excellent financial health rating, but there are some minor concerns on its profitability.
ARGX Financial Highlights
Over the last trailing twelve months ARGX reported a non-GAAP Earnings per Share(EPS) of 9.27. The EPS increased by 345.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 41.97% | ||
| ROA | 17.84% | ||
| ROE | 21% | ||
| Debt/Equity | 0.01 |
ARGX Forecast & Estimates
25 analysts have analysed ARGX and the average price target is 831.9 USD. This implies a price increase of 9.12% is expected in the next year compared to the current price of 762.385.
For the next year, analysts expect an EPS growth of 754% and a revenue growth 81.09% for ARGX